Sutro Biopharma, Inc.
South San Francisco,
Sutro Biopharma is looking for a talented and energetic team player to help drive preclinical/clinical advancement of our drug portfolios within the Translational Pharmacology and Preclinical Development (TP/PD) group.
Symic Biomedical is a private, venture-backed preclinical-stage platform biopharma company and has raised $43 million since being founded in 2012. Symic has a pipeline of novel macro-molecules that mimic structural components of the extracellular...